#1 Clinical Trials Search in Europe

Labetalol Hydrochloride

Labetalol Hydrochloride, a medication used to treat high blood pressure, is being studied in various clinical trials to explore its potential benefits in different medical conditions. These trials aim to investigate the drug’s effectiveness in managing blood pressure during pregnancy, reducing the risk of preeclampsia in obese patients, and controlling blood pressure during endoscopic nasal surgeries. Additionally, researchers are examining its role in managing acute cerebral hemorrhage. This article summarizes the key findings and objectives of these clinical trials involving Labetalol Hydrochloride.

Table of Contents

What is Labetalol Hydrochloride?

Labetalol Hydrochloride, also known by the brand name Trandate, is a medication that belongs to a class of drugs called beta-blockers[1]. It is primarily used to treat high blood pressure (hypertension) and has unique properties that make it effective in various medical situations.

Medical Uses of Labetalol

Labetalol is used in several medical conditions, including:

  • Hypertension in Pregnancy: It is commonly used to treat high blood pressure in pregnant women, especially those at risk of developing preeclampsia (a pregnancy complication characterized by high blood pressure and signs of damage to other organ systems)[1].
  • Controlled Hypotensive Anesthesia: Labetalol is used to lower blood pressure during certain surgical procedures, such as endoscopic nasal surgeries, to reduce bleeding and improve visibility for surgeons[2].
  • Acute Cerebral Hemorrhage: It is being studied for its potential to reduce blood pressure in patients who have experienced bleeding in the brain (intracerebral hemorrhage)[3].

How Labetalol Works

Labetalol works by blocking both alpha and beta receptors in the body. This dual action helps to:

  • Reduce the heart rate
  • Decrease the force of heart contractions
  • Relax blood vessels

By doing this, Labetalol effectively lowers blood pressure and can help control other cardiovascular symptoms[1][2].

Dosage and Administration

The dosage of Labetalol can vary depending on the specific medical condition and individual patient factors. Some common dosages observed in clinical trials include:

  • For treating hypertension in pregnancy: 200 mg orally every 12 hours[1]
  • For controlled hypotensive anesthesia: 200 mg oral tablet as premedication[2]

It’s important to note that dosage should always be determined by a healthcare professional based on individual patient needs and medical history.

Potential Side Effects

Like all medications, Labetalol can cause side effects. Some potential side effects observed in clinical trials include[2]:

  • Bradycardia: Abnormally slow heart rate
  • Hypotension: Low blood pressure
  • Dysrhythmia: Irregular heartbeat
  • Bronchospasm: Tightening of the airways in the lungs
  • Postoperative nausea and vomiting (PONV)

It’s important to discuss any concerns about side effects with your healthcare provider.

Current Research and Clinical Trials

Labetalol is currently being studied in several clinical trials:

  1. Prevention of Preeclampsia in Obese Patients: A study is investigating whether using Labetalol based on impedance cardiography (a non-invasive method to measure heart function) can help reduce the risk of preeclampsia in obese pregnant women[1].
  2. Controlled Hypotensive Anesthesia: Researchers are comparing the effectiveness of Labetalol to another beta-blocker, Metoprolol, in reducing bleeding during endoscopic nasal surgeries[2].
  3. Acute Cerebral Hemorrhage Treatment: A large-scale study is examining whether early intensive blood pressure lowering with medications like Labetalol can improve outcomes in patients who have experienced bleeding in the brain[3].

These ongoing studies aim to expand our understanding of Labetalol’s potential uses and effectiveness in various medical conditions.

Trial Focus Use of Labetalol Hydrochloride Key Objectives Patient Population
Preeclampsia in Obese Patients Antihypertensive medication Reduce risk of preeclampsia Morbidly obese pregnant women (BMI ≥ 40)
Endoscopic Nasal Surgeries Premedication for controlled hypotensive anesthesia Reduce blood loss and maintain stable blood pressure Patients undergoing endoscopic nasal surgeries
Acute Cerebral Hemorrhage Early intensive blood pressure lowering Reduce mortality and disability Patients with stroke due to intracerebral hemorrhage

FAQ

  • What is Labetalol Hydrochloride used for in these clinical trials? In these trials, Labetalol Hydrochloride is being studied for various uses, including managing blood pressure in pregnant obese patients to reduce preeclampsia risk, controlling blood pressure during endoscopic nasal surgeries, and potentially improving outcomes in patients with acute cerebral hemorrhage.
  • How is Labetalol Hydrochloride being used in the trial for obese pregnant patients? In the trial for obese pregnant patients, Labetalol Hydrochloride is being used as one of the antihypertensive medications to treat patients with abnormal impedance cardiography results. The goal is to see if normalizing these parameters can decrease the incidence of preeclampsia and other pregnancy complications.
  • What is the purpose of using Labetalol in the endoscopic nasal surgery trial? In the endoscopic nasal surgery trial, Labetalol is being compared to Metoprolol as a premedication for controlled hypotensive anesthesia. The aim is to determine which drug is more effective in reducing blood loss and maintaining stable blood pressure during surgery.
  • How is Labetalol being used in the acute cerebral hemorrhage trial? In the acute cerebral hemorrhage trial, Labetalol is one of several medications being studied for early intensive blood pressure lowering. The goal is to determine if this approach can reduce the chances of death or long-term disability in patients with stroke due to intracerebral hemorrhage.
  • What are some potential side effects of Labetalol Hydrochloride mentioned in these trials? While specific side effects are not extensively discussed in the trial summaries, potential side effects of antihypertensive medications like Labetalol may include bradycardia (slow heart rate), hypotension (low blood pressure), dysrhythmia (irregular heartbeat), and bronchospasm (tightening of the airways).

Ongoing Clinical Trials on Labetalol Hydrochloride

  • Study on Blood Pressure Management with Urapidil, Phenylephrine, and Labetalol for Patients with Acute Ischemic Stroke After Endovascular Therapy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Preeclampsia: A pregnancy complication characterized by high blood pressure and signs of damage to another organ system, most often the liver and kidneys. It usually begins after 20 weeks of pregnancy in women whose blood pressure had been normal.
  • Impedance Cardiography: A non-invasive method of measuring cardiac output and other hemodynamic parameters using electrical impedance across the chest.
  • Morbid Obesity: A severe level of obesity, typically defined as having a Body Mass Index (BMI) of 40 or higher.
  • Controlled Hypotensive Anesthesia: A technique used during surgery to deliberately lower a patient's blood pressure to reduce bleeding and improve surgical conditions.
  • Intracerebral Hemorrhage (ICH): A type of stroke caused by bleeding within the brain tissue itself.
  • Modified Rankin Score: A scale used to measure the degree of disability or dependence in daily activities of people who have suffered a stroke or other neurological disability.
  • Haematoma Expansion: The increase in size of a collection of blood (haematoma) within the brain tissue following an initial bleed.
  • Cerebral Oedema: Swelling of the brain tissue, often occurring as a complication of brain injury or stroke.

References

  1. https://clinicaltrials.gov/study/NCT03105661
  2. https://clinicaltrials.gov/study/NCT05368376
  3. https://clinicaltrials.gov/study/NCT00226096